🔓
Sign in as a Member to unlock the full view of S.4120. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$29.99/mo already a Member? Sign in →
S.4120 · 117TH CONGRESS

Childhood Cancer STAR Reauthorization Act

Status
Enacted into Law
Official Source
Investability
67/100
Stage
ENACTED
Related Bills
1
Full Text
4,764 chars
Status
PASSED

What This Bill Does · Plain English

GovGreed Synthesis · AI extraction
This bill reauthorizes and amends existing federal programs focused on childhood cancer research, survivorship care, and data collection. It extends funding authorizations for the National Institutes of Health's children's cancer biorepository and related survivorship research programs from 2024 through 2028. The bill also updates program language to emphasize research over pilot programs, includes adolescents in survivorship studies, and directs a report on reducing administrative burdens for researchers accessing biorepository samples.

Action Timeline

2023-01-05
Became Public Law No: 117-350.
2023-01-05
Signed by President.
2023-01-05
Signed by President.
2023-01-05
Became Public Law No: 117-350.
2022-12-28
Presented to President.
2022-12-28
Presented to President.
2022-12-22
DEBATE - The House proceeded with forty minutes of debate on S. 4120.
2022-12-22
Motion to reconsider laid on the table Agreed to without objection.
2022-12-22
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H10025-10026)
2022-12-22
Mr. Pallone moved to suspend the rules and pass the bill.

Frequently Asked Questions

Did S.4120 pass?
Yes. S.4120 (Childhood Cancer STAR Reauthorization Act) was enacted into law. Bill stage: ENACTED.
What does S.4120 do?
This bill reauthorizes and amends existing federal programs focused on childhood cancer research, survivorship care, and data collection. It extends funding authorizations for the National Institutes of Health's children's cancer biorepository and related survivorship research programs from 2024 through 2028. The bill also updates program language to emphasize research over pilot programs, includes adolescents in survivorship studies, and directs a report on reducing administrative burdens for researchers accessing biorepository samples.

Full Bill Text

115 S4120 ENR: Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 U.S. Senate text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. One Hundred Seventeenth Congress of the United States of America 2d Session Begun and held at the City of Washington on Monday, the third day of January, two thousand and twenty two S. 4120 IN THE SENATE OF THE UNITED STATES AN ACT To maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes. 1. Short title This Act may be cited as the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act . 2. Reauthorizing and improving the Childhood STAR Act (a) Children's cancer biorepositories Section 417E of the Public Health Service Act ( 42 U.S.C. 285a–11 ) is amended— (1) in subsection (a)— (A) in paragraph (2)(A), by inserting before the period at the end of the second sentence the following: , such as collected samples of both solid tumor cancer and paired samples ; (B) in paragraph (9), by striking Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 and inserting Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 ; (C) by redesignating paragraph (10) as paragraph (11); and (D) by inserting after paragraph (9) the following: (10) Report on researcher access to children's cancer biorepository samples Not later than 2 years after the date of enactment of the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 , the Director of NIH shall— (A) conduct a review of the procedures established under paragraph (2)(C) and other policies or procedures related to researcher access to such biospecimens to identify any opportunities to reduce administrative burden, consistent with paragraph (2)(D), in a manner that protects personal privacy to the extent required by applicable Federal and State privacy law, at a minimum; and (B) submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the findings of the review under subparagraph (A) and whether the Director of NIH plans to make any changes to the policies or procedures considered in such review, based on such findings. ; and (2) in subsection (d), by striking 2019 through 2023 and inserting 2024 through 2028 . (b) Cancer survivorship programs Section 201 of the Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 ( Public Law 115–180 ) is amended— (1) in subsection (a)— (A) in the subsection heading, by striking Pilot programs to explore and inserting Research to evaluate (B) in paragraph (1)— (i) by striking may make awards to eligible entities to establish pilot programs and inserting shall, as appropriate, make awards to eligible entities to conduct or support research ; (ii) by striking model systems and inserting approaches ; (iii) by inserting and adolescent after childhood ; and (iv) by striking evaluation of models for ; (C) in paragraph (2)— (i) in subparagraph (A), in the matter preceding clause (i), by inserting within the existing peer review process, after practicable, ; and (ii) in subparagraph (B)(v), by striking in treating survivors of childhood cancers and inserting in carrying out the activities described in paragraph (1) ; and (D) in paragraph (3)(B)(v), by striking design of systems for the effective transfer of treatment information and care summaries from cancer care providers to other health care providers and inserting design tools to support the secure electronic transfer of treatment information and care summaries between health care providers or, as applicable and appropriate, longitudinal childhood cancer survivorship cohorts ; and (2) in subsection (b)— (A) in each of paragraphs (1) and (2), by striking date of enactment of this Act and inserting date of enactment of the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 ; and (B) in paragraph (1)— (i) by striking subparagraphs (A) and (C); (ii) by redesignating subparagraph (B) as subparagraph (A); and (iii) by adding at the end the following: (B) recommendations for enhancing or promoting activities of the Department of Health and Human Services related to workforce development for health care providers who provide psychosocial care to pediatric cancer patients and survivors. . Speaker of the House of Representatives Vice President of the United States and President of the Senate
🔒 GovGreed Pro · Trading Intelligence on S.4120 Get Access — $29.99/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-11-17. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]